Experience with hypofractionated stereotactic radiosurgery in a series of patients with skull base tumors

2018 ◽  
Vol 7 (4) ◽  
pp. 307-315
Author(s):  
Diego Aldo Hernández ◽  
Juan M. Zaloff Dakoff ◽  
Cynthia Auad ◽  
Víctor Eduardo Derechinsky ◽  
Roberto Rosler ◽  
...  
Keyword(s):  
Skull Base ◽  
Stereotactic Radiosurgery ◽  
Skull Base Tumors ◽  
Hypofractionated Stereotactic Radiosurgery

The Evolving Role of Stereotactic Radiosurgery for Patients with Skull Base Tumors

2004 ◽  
Vol 69 (1-3) ◽  
pp. 199-207 ◽  
Author(s):  
Bruce E. Pollock ◽  
Robert L. Foote
Keyword(s):  
Skull Base ◽  
Stereotactic Radiosurgery ◽  
Skull Base Tumors

scholarly journals Stereotactic Radiosurgery and Stereotactic Radiotherapy for Malignant Skull Base Tumors

Cureus ◽  
2020 ◽  
Author(s):  
Yoshimasa Mori ◽  
Yoshihisa Kida ◽  
Yasuhiro Matsushita ◽  
Shinichiro Mizumatsu ◽  
Manabu Hatano
Keyword(s):  
Skull Base ◽  
Stereotactic Radiosurgery ◽  
Stereotactic Radiotherapy ◽  
Skull Base Tumors

Stereotactic Radiosurgery of Skull Base Tumors

2010 ◽  
pp. 785-798
Author(s):  
P. Ashley Wackym ◽  
Christina L. Runge-Samuelson ◽  
David R. Friedland
Keyword(s):  
Skull Base ◽  
Stereotactic Radiosurgery ◽  
Skull Base Tumors

Hypofractionated stereotactic radiosurgery for large-sized skull base meningiomas

2020 ◽  
Vol 149 (1) ◽  
pp. 87-93 ◽  
Author(s):  
Hyuk-Jin Oh ◽  
Young Hyun Cho ◽  
Jeong Hoon Kim ◽  
Chang Jin Kim ◽  
Do Hoon Kwon ◽  
...  
Keyword(s):  
Skull Base ◽  
Stereotactic Radiosurgery ◽  
Skull Base Meningiomas ◽  
Hypofractionated Stereotactic Radiosurgery

The role of stereotactic radiosurgery in the treatment of malignant skull base tumors

1997 ◽  
Vol 39 (5) ◽  
pp. 977-981 ◽  
Author(s):  
Robert C. Miller ◽  
Robert L. Foote ◽  
Robert J. Coffey ◽  
Deborah A. Gorman ◽  
John D. Earle ◽  
...  
Keyword(s):  
Skull Base ◽  
Stereotactic Radiosurgery ◽  
Skull Base Tumors

Stereotactic Radiosurgery for Trigeminal Pain Secondary to Benign Skull Base Tumors

2013 ◽  
Vol 80 (3-4) ◽  
pp. 371-377 ◽  
Author(s):  
Shota Tanaka ◽  
Bruce E. Pollock ◽  
Scott L. Stafford ◽  
Michael J. Link
Keyword(s):  
Skull Base ◽  
Stereotactic Radiosurgery ◽  
Skull Base Tumors ◽  
Trigeminal Pain

scholarly journals Stereotactic radiosurgery for intracranial meningiomas: indications and results

2003 ◽  
Vol 14 (5) ◽  
pp. 1-7 ◽  
Author(s):  
Bruce E. Pollock
Keyword(s):  
Skull Base ◽  
Stereotactic Radiosurgery ◽  
Cyst Formation ◽  
Primary Treatment ◽  
Management Approach ◽  
Tumor Control ◽  
Skull Base Tumors ◽  
Intracranial Meningiomas ◽  
Prior Surgery ◽  
Cranial Neuropathies

Object Stereotactic radiosurgery (SRS) has become an important treatment option for patients with intracranial meningiomas. The author reviews the 12-year experience at a single institution and discusses the relative strengths and weakness of this management approach. Methods Between January 1990 and December 2002, 330 patients (with 356 tumors) underwent radiosurgery for intracranial meningiomas. One hundred thirty-eight patients (42%) harbored recurrent/residual tumors after having already undergone resection; 192 patients (58%) underwent radiosurgery as primary treatment. The majority of patients (70%) harbored skull base tumors. The median tumor volume was 7.3 cm3 (range 0.5–50.5 cm3). The median tumor margin dose was 16 Gy (range 12–20 Gy). In 278 patients with 297 lesions the mean clinical and imaging follow-up period was 43 months (range 2–138 months). Two hundred seventy-eight tumors (94%) remained stable or decreased in size, and 19 tumors progressed in size. Factors associated with progression were tumor histological type and prior surgery. Treatment-related complications occurred in 8% of the patients and included cranial neuropathies, symptomatic edema, cyst formation, and stenosis of the internal carotid artery. In three patients (1%) tumor dedifferentiation was noted after SRS. Conclusions Radiosurgical treatment of meningioma is safe and it has become the primary treatment for patients with small skull base tumors. Further study is needed to determine the long-term tumor control rates after such treatment, especially for patients treated with doses of 14 Gy or less.

Sign in / Sign up

Export Citation Format

Share Document